152 related articles for article (PubMed ID: 9681807)
21. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence.
Visscher DW; Höyhtyä M; Ottosen SK; Liang CM; Sarkar FH; Crissman JD; Fridman R
Int J Cancer; 1994 Nov; 59(3):339-44. PubMed ID: 7927938
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
Schwandner O; Schlamp A; Broll R; Bruch HP
Int J Colorectal Dis; 2007 Feb; 22(2):127-36. PubMed ID: 16896992
[TBL] [Abstract][Full Text] [Related]
23. [Helicobacter pylori infection, the invasion and metastasis of the gastric carcinoma, and the expression of MMP-2 and TIMP-2].
Xu CX; Zhong H; Shen SR
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):643-6. PubMed ID: 16114547
[TBL] [Abstract][Full Text] [Related]
24. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
Jones JL; Glynn P; Walker RA
J Pathol; 1999 Oct; 189(2):161-8. PubMed ID: 10547569
[TBL] [Abstract][Full Text] [Related]
25. Immunoexpression of metalloproteinases 2 and 14 and TIMP-2 inhibitor in main types of primary gastric carcinomas and lymph node metastasis.
Gurgel DC; Valença-Junior JT; Dornelas CA; Vieira RB; Maia-Filho JT; Lima-Junior RC; Ribeiro RA; Almeida PR
Pathol Oncol Res; 2015 Jan; 21(1):73-81. PubMed ID: 24800696
[TBL] [Abstract][Full Text] [Related]
26. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
[TBL] [Abstract][Full Text] [Related]
27. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.
Katayama A; Bandoh N; Kishibe K; Takahara M; Ogino T; Nonaka S; Harabuchi Y
Clin Cancer Res; 2004 Jan; 10(2):634-40. PubMed ID: 14760086
[TBL] [Abstract][Full Text] [Related]
28. Augmented membrane type 1 matrix metalloproteinase (MT1-MMP):MMP-2 messenger RNA ratio in gastric carcinomas with poor prognosis.
Caenazzo C; Onisto M; Sartor L; Scalerta R; Giraldo A; Nitti D; Garbisa S
Clin Cancer Res; 1998 Sep; 4(9):2179-86. PubMed ID: 9748137
[TBL] [Abstract][Full Text] [Related]
29. Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
Kim TS; Kim YB
J Korean Med Sci; 1999 Jun; 14(3):263-70. PubMed ID: 10402168
[TBL] [Abstract][Full Text] [Related]
30. Timp-1, -2 and -3 show coexpression with gelatinases A and B during mouse tooth morphogenesis.
Sahlberg C; Reponen P; Tryggvason K; Thesleff I
Eur J Oral Sci; 1999 Apr; 107(2):121-30. PubMed ID: 10232461
[TBL] [Abstract][Full Text] [Related]
31. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
[TBL] [Abstract][Full Text] [Related]
32. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
Hirata M; Sato T; Tsumagari M; Shimada A; Nakano H; Hashizume K; Ito A
Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma.
Kikuchi R; Noguchi T; Takeno S; Kubo N; Uchida Y
Br J Cancer; 2000 Jul; 83(2):215-8. PubMed ID: 10901373
[TBL] [Abstract][Full Text] [Related]
34. The expression of MMP-2 and TIMP-2 in patients with primary colorectal adenocarcinoma: correlation with liver metastasis.
Mukai M; Sadahiro S; Tokunaga N; Ishizu K; Ito I; Kameya T; Ishikawa K; Iwase H; Suzuki T; Ishida H; Tajima T; Makuuchi H
Oncol Rep; 1999; 6(5):969-73. PubMed ID: 10425288
[TBL] [Abstract][Full Text] [Related]
35. [Effects of TIMP-2 gene transfection on biological behaviors of a metastatic human lung carcinoma cell line].
Li H; Fang W; Shi Z
Zhonghua Yi Xue Za Zhi; 1997 Sep; 77(9):652-6. PubMed ID: 9772531
[TBL] [Abstract][Full Text] [Related]
36. Role of matrix metalloproteinase (MMP) 2 and MMP-9 in soft tissue sarcoma.
Yang HK; Jeong KC; Kim YK; Jung ST
Clin Orthop Surg; 2014 Dec; 6(4):443-54. PubMed ID: 25436070
[TBL] [Abstract][Full Text] [Related]
37. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
Nakagawa T; Kubota T; Kabuto M; Sato K; Kawano H; Hayakawa T; Okada Y
J Neurosurg; 1994 Jul; 81(1):69-77. PubMed ID: 8207529
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinases and their inhibitors.
Kugler A
Anticancer Res; 1999; 19(2C):1589-92. PubMed ID: 10365151
[TBL] [Abstract][Full Text] [Related]
39. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
Kayano K; Shimada T; Shinomiya T; Nakai S; Hisa Y; Aoki T; Seiki M; Okada Y
J Pathol; 2004 Apr; 202(4):403-11. PubMed ID: 15095267
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
